Startseite Kongressberichte 2020 All-Virtual 62nd ASH Annual Meeting and Exposition Oral Sessions Acute Myeloid Leukemia AML - Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis III

617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Dissecting AML heterogeneity to refine treatment approaches

Andy G.X. Zeng, Amanda Mitchell, Oleksandr Galkin, et al.